Karyometry detects subvisual differences in chromatin organisation state between non-recurrent and recurrent papillary urothelial neoplasms of low malignant potential
暂无分享,去创建一个
P H Bartels | P W Hamilton | M Scarpelli | R Montironi | P. Bartels | P. Hamilton | R. Montironi | M. Scarpelli | J. Ranger-Moore | L M Tarquini | A López Beltran | J Ranger-Moore | L. Tarquini | A. López Beltran
[1] W. Kruskal,et al. Use of Ranks in One-Criterion Variance Analysis , 1952 .
[2] Lawrence D. True,et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .
[3] G. Mikuz,et al. Quantitative assessment of bladder cancer by nuclear texture analysis using automated high resolution image cytometry. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[4] J. McKenney,et al. Relationship of Cytokeratin 20 and CD44 Protein Expression with WHO/ISUP Grade in pTa and pT1 Papillary Urothelial Neoplasia , 2000, Modern Pathology.
[5] James Ranger-Moore,et al. Subvisual changes in chromatin organization state are detected by karyometry in the histologically normal urothelium in patients with synchronous papillary carcinoma. , 2003, Human pathology.
[6] K. Grigor,et al. Identification of loci associated with putative recurrence genes in transitional cell carcinoma of the urinary bladder , 2002, The Journal of pathology.
[7] H. Samaratunga,et al. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. , 2002, Urology.
[8] D. Bostwick,et al. Papillary urothelial neoplasms of low malignant potential , 1999, Cancer.
[9] D. Bostwick,et al. Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies , 2003, Journal of clinical pathology.
[10] A. Llombart‐Bosch,et al. Cytokeratin expression patterns in low‐grade papillary urothelial neoplasms of the urinary bladder , 2003, Cancer.
[11] C. Busch,et al. Recurrence and progression in low grade papillary urothelial tumors. , 1999, The Journal of urology.
[12] Robert M. Haralick,et al. Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..
[13] P. Bartels,et al. Karyometry of secretory cell nuclei in high‐grade PIN lesions * , 2001, The Prostate.
[14] T. Cremer,et al. Chromosome territories, nuclear architecture and gene regulation in mammalian cells , 2001, Nature Reviews Genetics.
[15] Christer Busch,et al. The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems , 2002, Virchows Archiv.
[16] P H Bartels,et al. Chromatin texture signatures in nuclei from prostate lesions. , 1998, Analytical and quantitative cytology and histology.
[17] P. Bartels,et al. Evaluation of the Papanicolaou stain for computer assisted cellular pattern recognition. , 1973, Acta Cytologica.
[18] E. Jones,et al. Comparison of the WHO/ISUP Classification and Cytokeratin 20 Expression in Predicting the Behavior of Low-Grade Papillary Urothelial Tumors , 2001, Modern Pathology.
[19] A. Formiconi,et al. Biologic Differences Between Noninvasive Papillary Urothelial Neoplasms of Low Malignant Potential and Low-Grade (Grade 1) Papillary Carcinomas of the Bladder , 2001, The American journal of surgical pathology.
[20] J. Köllermann,et al. Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: a contribution to the new WHO classification of the urothelial tumors of the urinary bladder. , 2000, Human pathology.
[21] C. Cinti,et al. pRb2/p130 and p107 control cell growth by multiple strategies and in association with different compartments within the nucleus * , 2001, Journal of cellular physiology.
[22] V. Reuter,et al. Bladder biopsy interpretation , 2004 .
[23] T De Wilde,et al. Identification by quantitative chromatin pattern analysis of patients at risk for recurrence of superficial transitional bladder carcinoma. , 2000, The Journal of urology.
[24] P. Bartels,et al. Computer Analysis of Lymphocyte Images , 1980 .
[25] D. N. Sparks. Euclidean Cluster Analysis , 1973 .
[26] A. Formiconi,et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder , 2002, Cancer.
[27] J. Epstein,et al. Correlation of Ki-67 and p53 with the new World Health Organization/International Society of Urological Pathology Classification System for Urothelial Neoplasia. , 2009 .
[28] L. Sobin,et al. Histological Typing of Urinary Bladder Tumours , 1999, International Histological Classification of Tumours.
[29] B H Mayall,et al. Characterization of chromatin distribution in cell nuclei. , 1986, Cytometry.
[30] J. Southgate,et al. Cytokeratin 20 expression by non‐invasive transitional cell carcinomas: potential for distinguishing recurrent from non‐recurrent disease , 1995, Histopathology.
[31] David G. Bostwick,et al. Urothelial papillary (exophytic) neoplasms , 2002, Virchows Archiv.